Vision Cooperative Research Centre, Rupert Myers Building, Sydney, NSW 2052, Australia.
Biomaterials. 2011 Apr;32(12):3158-65. doi: 10.1016/j.biomaterials.2011.01.047.
This study assessed the long-term biological response of a perfluoropolyether-based polymer developed as a corneal inlay to correct refractive error. The polymer formulation met chemical and physical specifications and was non-cytotoxic when tested using standard in vitro techniques. It was cast into small microporous membranes that were implanted as inlays into corneas of rabbits (n = 5) and unsighted humans (n = 5 + 1 surgical control) which were monitored for up to 23 and 48 months respectively. Overall, the inlays were well tolerated during study period with the corneas remaining clear and holding a normal tear film and with no increased vascularisation or redness recorded. Inlays in three human corneas continued past 48 months without sequelae. Inlays in two human corneas were removed early due to small, focal erosions developing 5 and 24 months post-implantation. Polymer inlays maintained their integrity and corneal position for the study duration although the optical clarity of the inlays reduced slowly with time. Inlays induced corneal curvature changes in human subjects that showed stability with time and the refractive effect was reversed when the inlay was removed. Outcomes showed the potential of a perfluoropolyether inlay as a biologically acceptable corneal implant with which to provide stable correction of refractive error.
本研究评估了一种作为角膜嵌体用于矫正屈光不正的全氟聚醚基聚合物的长期生物学反应。该聚合物配方符合化学和物理规格,并且使用标准的体外技术进行测试时无细胞毒性。它被浇铸成小的微孔膜,作为嵌体植入兔子(n=5)和盲人(n=5+1 手术对照)的角膜中,分别监测长达 23 个月和 48 个月。总体而言,在研究期间,嵌体的耐受性良好,角膜保持透明,保持正常的泪膜,没有记录到血管化或红肿增加。在三个人的角膜中,嵌体在 48 个月后仍未出现后遗症。由于植入后 5 个月和 24 个月出现小的局灶性侵蚀,两个人的角膜中的嵌体被早期取出。尽管随着时间的推移,嵌体的光学清晰度缓慢降低,但聚合物嵌体在整个研究期间保持其完整性和角膜位置。在人类受试者中,嵌体诱导角膜曲率变化,这些变化随时间显示出稳定性,并且当嵌体被移除时,屈光效果会逆转。研究结果表明,全氟聚醚嵌体作为一种具有生物可接受性的角膜植入物具有潜力,可提供稳定的屈光不正矫正效果。
Biomaterials. 2011-4
Invest Ophthalmol Vis Sci. 2006-2
Clin Exp Optom. 2008-1
Invest Ophthalmol Vis Sci. 2002-10
Trans Ophthalmol Soc U K (1962). 1985
Invest Ophthalmol Vis Sci. 2006-5
J Cataract Refract Surg. 2005-2